Venus Remedies Limited’s R3SET division embarks on wellness journey with expanded offerings

Venus Remedies Limited’s R3SET division embarks on wellness journey with expanded offerings

Venus Remedies Limited, a leader in pharmaceutical research and development, has announced a major transformation of its consumer healthcare division, R3SET. This strategic pivot marks a significant foray into the wellness arena, showcasing the company’s commitment to holistic wellness solutions, alongside an expansion of its pain management portfolio. Entering the Wellness Domain with R3SET Detox […]

Venus Remedies expands global reach with market authorizations in Saudi Arabia and Philippines

Venus Remedies expands global reach with market authorizations in Saudi Arabia and Philippines

Venus Remedies Limited, a prominent player in the global pharmaceutical industry, announced its latest achievement of receiving marketing authorizations for critical healthcare products in Saudi Arabia and the Philippines. This development marks a significant expansion of the company’s global presence. Approvals for Paclitaxel and Zolendronic Acid in the Philippines The company secured marketing authorizations for […]

Venus Remedies expands globally with Elores launch in Ecuador: Tackling multi-drug-resistant infections

Venus Remedies expands globally with Elores launch in Ecuador: Tackling multi-drug-resistant infections

Venus Remedies Limited, renowned for healthcare innovation, continues its global growth trajectory with the latest launch of its cutting-edge antibiotic formulation, Elores, in Ecuador. Building on previous successful launches in countries including India, Saudi Arabia, and Tanzania, this expansion further cements the company’s commitment to tackling antibiotic resistance on a global scale. Elores stands out […]

Venus Remedies expands cancer drug portfolio in South Eastern Europe

Venus Remedies expands cancer drug portfolio in South Eastern Europe

In a significant development for its oncology portfolio in South Eastern Europe, Venus Remedies Ltd has been granted marketing authorization from Serbia for chemotherapy drugs gemcitabine and docetaxel. This approval takes the company’s total marketing authorizations for oncology products to 511 across 66 countries. It marks another crucial step toward Venus Remedies’ ambition of becoming […]

Venus Remedies secures marketing authorization for Meropenem in Spain

Venus Remedies secures marketing authorization for Meropenem in Spain

Venus Remedies has made a significant stride by securing marketing authorization from Spain for its top-selling generic product, meropenem. The Indian pharmaceutical company obtained this approval through its German subsidiary Venus Pharma GmbH for the distribution of 500mg, 1g, and 2g injections of this last-resort antibiotic, reinforcing its standing as the largest exporter of meropenem […]

Venus Remedies gets GMP certification from Ukraine for Carbapenem, oncology parenteral plants

Venus Remedies gets GMP certification from Ukraine for Carbapenem, oncology parenteral plants

Venus Remedies, an Indian pharmaceutical company, has secured Good Manufacturing Practices (GMP) certification from Ukraine for the production facilities of some of its pharmaceutical products. These include Meropenem 500mg, Meropenein 1000mg, Meropenem 2000mg, Oxaliplatin 5mg/ml, Paclitaxil 6mg/ml, Cisplatin 1mg/ml, and Imipenem/Cilastatin 500mg/500mg at their manufacturing unit in Baddi, Himachal Pradesh. The State Service of Ukraine […]

Venus Remedies forays into consumer healthcare market with R3SET Life

Venus Remedies forays into consumer healthcare market with R3SET Life

Venus Remedies, a Chandigarh-based pharma company, has forayed into the Indian consumer healthcare market, with the launch of R3SET, a holistic pain management solution. According to Venus Remedies, R3SET Life combines the goodness of essential oils with nanotechnology to give instant relief and long-term healing. R3SET has ingredients such as wintergreen berries and a mix […]